Efsun TANAÇAN, Nermin KARAOSMANOĞLU, Ömer KUTLU, Hatice Meral EKŞİOĞLU

ANDROGENETİK ALOPESİ ŞİDDETİ VE VÜCUT KİTLE İNDEKSİ ARASINDAKİ İLİŞKİNİN DEĞERLENDİRİLMESİ

AMAÇ: Bu çalışmanın amacı, androgenetik alopesi (AGA)şiddeti ile vücut kitle indeksi (VKİ) arasında bir ilişki bulunupbulunmadığını değerlendirmektir.GEREÇ VE YÖNTEMLER: Bu çalışmaya Sağlık BilimleriÜniversitesi Ankara Eğitim ve Araştırma Hastanesi DermatolojiKliniği’ne AGA tanısı ile başvuran toplam 132 hasta dahil edildi.Çalışmaya alınan AGA’lı erkek hastalar Hamilton-NorwoodSınıflaması’ndaki (HNS) alopesi şiddetine göre 3 gruba ayrıldı: grup1 ( HNS Tip 1 ve 2), grup 2 (HNS Tip 3-4-5) ve grup 3 (HNS Tip6-7). Hasta yaşı ve VKİ değerleri gruplar arasında karşılaştırıldı.Hastalardan çalışma için onam alındı.BULGULAR: Hastaların yaş ortalaması 45.62±16.09 yıl olarakbulundu. Ortalama VKİ değeri ise 24.62±1.74 kg/m2 olarak bulundu.Grup 1,2 ve 3’te sırasıyla 40, 46 ve 46 hasta bulunmaktaydı. Grup 1, 2ve 3’teki ortanca VKİ değerleri sırasıyla, 24.30, 24.70 ve 24.25 kg/m2olarak bulundu. Grup 1, 2 ve 3’teki ortanca yaş değerleri sırasıyla,27.5, 45 ve 64.5 yıl olarak bulundu. Androgenetik alopesi şiddeti ileVKİ arasında istatistiksel olarak anlamlı ilişki bulunamadı (p=0.70).SONUÇ: Bu çalışmada AGA şiddeti ile VKİ arasında bir ilişkiolmadığı görülmüştür.

EVALUATION OF THE RELATIONSHIP BETWEEN ANDROGENETIC ALOPECIA SEVERITY AND BODY MASS INDEX

INTRODUCTION: To evaluate whether there is a relationship between androgenetic alopecia (AGA) severity and body mass index (BMI). MATERIAL AND METHODS: A total of 132 male patients with AGA who were admitted to the Dermatology Clinic of the University of Health Sciences Ankara Training and Research Hospital were included in this study. The patients were divided into three groups according to the Hamilton-Norwood classification (HNC): group 1 (HNC type 1 and 2), group 2 (HNC type 3-4-5) and group 3 (HNC type 6-7). Median patient age and BMI values were compared between the groups. RESULTS: Mean age and BMI values were 45.62 ± 16.09 and 24.62 ± 1.74, respectively. There were 40, 46, and 46 patients in groups 1, 2 and 3, respectively. The median BMI values in Groups 1, 2 and 3 were 24.30, 24.70 and 24.25, respectively. The median age values in Groups 1, 2 and 3 were 27.5, 45 and 64.5, respectively. There was no statistically significant relationship between androgenetic alopecia severity and BMI (p=0.70) CONCLUSIONS: In this study, no correlation was found between AGA severity and BMI.

PDF

___

1.)Chumlea WC, Rhodes T, Girman CJ et al. Family history and risk of hair loss. Dermatology. 2004;209(1):33-9.
2.)Kutlubay Z, Baglam S, Engin B, Serdaroglu S. Male androgenetic alopecia. Turkderm. 2014;48(Suppl 1):36-39.
3.)Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002 Nov 19;4(22):1-11.
4.)Kim BJ, Kim JY, Eun HC, Kwon OS, Kim MN, Ro BI. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol. 2006 Oct;33(10):696-9.
5.)Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, et al. Multi‐therapies in androgenetic alopecia: Review and clinical experiences. Dermatol Ther. 2016 Nov;29(6):424-432.
6.)Küster W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol. 1984;11(5):921-6.
7.)Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-65.
8.)Blair SN, Nichaman MZ, editors. The public health problem of increasing prevalence rates of obesity and what should be done about it. Mayo Clin Proc. 2002: Elsevier.
9.)Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26(1):20-4.
10.)Yang C-C, Hsieh F-N, Lin L-Y, Hsu C-K, Sheu H-M, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol. 2014 Feb;70(2):297-302.
11.)Ozbas Gok S, Akin Belli A, Dervis E. Is there really relationship between androgenetic alopecia and metabolic syndrome? Dermatol Res Pract. 2015;2015.
12.)Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95.
13.)Imperato-McGinley J, Zhu Y-S. Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198(1-2):51-9.
14.)Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol. 2003 Dec;121(6):1561-4.
15.)Rebora A. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. Arch Dermatol. 2001;137(7):943-7.
16.)Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63(3):420-9.
17.)Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17(3):220-2.
18.)Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia -as a marker of insulin resistance. Lancet. 2000;356(9236):1165-6.
19.)Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006;14(2).
20.)Nam S, Lee E, Kim K, Cha B, Song Y, Lim S, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21(5):355.
21.)Kamycheva E, Berg V, Jorde R. Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects. Endocrine. 2013;43(2):412-8.
22.)Su LH, Chen TH. Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Arch Dermatol. 2007;143(11):1401-6.